Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Freiburg im Breisgau, Germany – January 8, 2026 – Eleva, a pioneer in discovering and developing previously inaccessible biologics, today announced the appointment of Dr. Erich Rajkovic, MBA, as Chief...
Read More -
Steve Mode of Wayne Hayes Real Estate answers when buyers or sellers should choose a local real estate broker over a national or out-of-town option.
Read More
-
SUDAN LITIGATION: RULING CLEARS PATH FOR BNP PARIBAS APPEAL Paris, 8 January 2026 On the 7th of January 2026, the decision by the judge to certify the October verdict clears the path for BNP...
-
Vancouver, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- NEW EARTH RESOURCES CORP. (CSE: EATH) ("New Earth" or the "Company") is pleased to outline its planned exploration program for the SL...
-
Leuven, Belgium. January 8, 2026. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated to transforming patients’ lives with best-in-class medicines, today announced...
-
LONDON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd (“Engitix”), a biotech company targeting the extracellular matrix (ECM) to develop transformative therapies for cancer and fibrosis, today...
-
Heat Recovery Ventilation (HRV) Market Size, Share & Segmentation By Type, Application, Installation Type, End-User, Region, And Global Forecast 2026-2033
-
BOSTON, Mass. and ZURICH, Switzerland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced a strategic collaboration with University Hospital Zurich...
-
SIGNAUX GIRODSociété anonyme au capital de 13 422 500 €Siège social : 881, route des fontaines39400 BELLEFONTAINE646 050 476 R.C.S. LONS-LE-SAUNIERCode ISIN : FR0000060790 BILAN SEMESTRIEL S2.2025DU...
-
PRESS RELEASE Regulated Information*Public disclosure of inside information VGP NV announces the launch of a capped cash tender offer for its outstandingEUR 500,000,000 1.625 per cent. fixed rate...
-
Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and ChinaNew five-year data on vamorolone highlighted substantially...
-
Reference is made to the terms and conditions for the Bonds (the "Terms and Conditions"). Capitalised but not defined terms herein shall have the meaning as set out in the Terms and Conditions. Key...